
Sign up to save your podcasts
Or


Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.
By Modern Optometry5
1515 ratings
Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.

75 Listeners

1,136 Listeners

9,237 Listeners

7,952 Listeners

63 Listeners

80 Listeners

538 Listeners

5 Listeners

18 Listeners

20 Listeners

822 Listeners

21 Listeners

382 Listeners

19 Listeners

18 Listeners